Published in J Virol on July 08, 2009
Establishment of a reverse genetics system for studying human bocavirus in human airway epithelia. PLoS Pathog (2012) 1.43
Advances in human B19 erythrovirus biology. J Virol (2010) 1.10
Parvovirus diversity and DNA damage responses. Cold Spring Harb Perspect Biol (2013) 1.04
Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells. J Virol (2010) 1.00
Parvovirus B19 infection of human primary erythroid progenitor cells triggers ATR-Chk1 signaling, which promotes B19 virus replication. J Virol (2011) 1.00
Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFα. PLoS Pathog (2011) 0.99
Parvoviral left-end hairpin ears are essential during infection for establishing a functional intranuclear transcription template and for efficient progeny genome encapsidation. J Virol (2013) 0.91
Human parvovirus B19 DNA replication induces a DNA damage response that is dispensable for cell cycle arrest at phase G2/M. J Virol (2012) 0.88
Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication. J Virol (2013) 0.87
Roles of E4orf6 and VA I RNA in adenovirus-mediated stimulation of human parvovirus B19 DNA replication and structural gene expression. J Virol (2012) 0.86
SMC1-mediated intra-S-phase arrest facilitates bocavirus DNA replication. J Virol (2013) 0.86
Structure of the NS1 protein N-terminal origin recognition/nickase domain from the emerging human bocavirus. J Virol (2013) 0.85
Identification and Functional Analysis of Novel Nonstructural Proteins of Human Bocavirus 1. J Virol (2015) 0.85
Human Parvoviruses. Clin Microbiol Rev (2017) 0.84
Analysis of cis and trans Requirements for DNA Replication at the Right-End Hairpin of the Human Bocavirus 1 Genome. J Virol (2016) 0.81
Molecular characterization of human parvovirus B19 genotypes 2 and 3. Virology (2009) 0.81
Parvovirus b19 DNA CpG dinucleotide methylation and epigenetic regulation of viral expression. PLoS One (2012) 0.81
Internal polyadenylation of the parvovirus B19 precursor mRNA is regulated by alternative splicing. J Biol Chem (2011) 0.81
The human parvovirus B19 non-structural protein 1 N-terminal domain specifically binds to the origin of replication in the viral DNA. Virology (2013) 0.79
Inclusion of the central exon of parvovirus B19 precursor mRNA is determined by multiple splicing enhancers in both the exon and the downstream intron. J Virol (2010) 0.79
Human parvovirus B19: a mechanistic overview of infection and DNA replication. Future Virol (2015) 0.78
Alternative polyadenylation of human bocavirus at its 3' end is regulated by multiple elements and affects capsid expression. J Virol (2016) 0.77
Generation of an adenovirus-parvovirus chimera with enhanced oncolytic potential. J Virol (2012) 0.77
Structures of minute virus of mice replication initiator protein N-terminal domain: Insights into DNA nicking and origin binding. Virology (2014) 0.76
Phosphorylated STAT5 directly facilitates parvovirus B19 DNA replication in human erythroid progenitors through interaction with the MCM complex. PLoS Pathog (2017) 0.76
Parvovirus Expresses a Small Noncoding RNA That Plays an Essential Role in Virus Replication. J Virol (2017) 0.75
Granzyme B mediated function of Parvovirus B19-specific CD4(+) T cells. Clin Transl Immunology (2015) 0.75
Human Parvovirus Infection of Human Airway Epithelia Induces Pyroptotic Cell Death via Inhibiting Apoptosis. J Virol (2017) 0.75
Parvovirus B19 integration into human CD36+ erythroid progenitor cells. Virology (2017) 0.75
Mutations in the C-terminus of HBoV NS1 affect the function of NP1. Sci Rep (2017) 0.75
Parvovirus B19. N Engl J Med (2004) 6.83
In vitro replication of duplex circular DNA containing the simian virus 40 DNA origin site. Proc Natl Acad Sci U S A (1985) 5.16
Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62
Intrauterine parvovirus infection associated with hydrops fetalis. Lancet (1984) 3.99
Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum Gene Ther (2002) 3.92
In vitro resolution of covalently joined AAV chromosome ends. Cell (1990) 3.24
Replication of the B19 parvovirus in human bone marrow cell cultures. Science (1986) 2.75
Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein. J Virol (1995) 2.23
Life-threatening human parvovirus B19 infection in immunocompetent haemophilia. Lancet (1995) 2.18
Characterization and molecular cloning of a human parvovirus genome. Science (1984) 2.12
Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens. J Immunol (1999) 1.67
Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. J Virol (1988) 1.62
Molecular characterization of infectious clones of the minute virus of canines reveals unique features of bocaviruses. J Virol (2009) 1.61
In vitro replication of adeno-associated virus DNA. Proc Natl Acad Sci U S A (1992) 1.60
The adeno-associated virus type 2 Rep protein regulates RNA processing via interaction with the transcription template. Mol Cell Biol (2002) 1.51
Biochemical characterization of adeno-associated virus rep68 DNA helicase and ATPase activities. J Virol (1999) 1.45
Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood (2003) 1.45
Parvovirus initiator protein NS1 and RPA coordinate replication fork progression in a reconstituted DNA replication system. J Virol (2002) 1.43
The transcription profile of Aleutian mink disease virus in CRFK cells is generated by alternative processing of pre-mRNAs produced from a single promoter. J Virol (2006) 1.41
Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication. J Virol (2007) 1.40
Construction and sequencing of an infectious clone of the human parvovirus B19. Virology (2004) 1.39
The expression strategy of goose parvovirus exhibits features of both the Dependovirus and Parvovirus genera. J Virol (2005) 1.31
Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood (2005) 1.29
Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome. J Virol (2008) 1.26
Parvovirus B19-induced apoptosis of hepatocytes. J Virol (2004) 1.26
Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood (1990) 1.24
Purification, amplification and characterization of a population of human erythroid progenitors. Br J Haematol (1999) 1.15
Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet (1983) 1.15
Helper functions required for wild type and recombinant adeno-associated virus growth. Curr Gene Ther (2005) 1.14
Comparative characterization of rep proteins from the helper-dependent adeno-associated virus type 2 and the autonomous goose parvovirus. J Virol (1999) 1.11
Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation (1997) 1.10
Human parvovirus B19 nonstructural protein (NS1) induces cell cycle arrest at G(1) phase. J Virol (2003) 1.08
Two widely spaced initiator binding sites create an HMG1-dependent parvovirus rolling-hairpin replication origin. J Virol (2000) 1.06
Initiation of DNA replication at palindromic telomeres is mediated by a duplex-to-hairpin transition induced by the minute virus of mice nonstructural protein NS1. J Biol Chem (1998) 1.02
Minimum origin requirements for linear duplex AAV DNA replication in vitro. Virology (1995) 1.02
Infection of the erythroid cell line, KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity. J Virol Methods (1999) 1.01
Biological and immunological relations among human parvovirus B19 genotypes 1 to 3. J Virol (2007) 1.00
Complete in vitro reconstitution of adeno-associated virus DNA replication requires the minichromosome maintenance complex proteins. J Virol (2007) 0.99
Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells. Proc Natl Acad Sci U S A (1995) 0.99
A cis-acting element that directs circular adeno-associated virus replication and packaging. J Virol (2002) 0.96
Purification of host cell enzymes involved in adeno-associated virus DNA replication. J Virol (2007) 0.96
Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells. J Virol (2008) 0.96
Detection of template strand switching during initiation and termination of DNA replication of porcine circovirus. J Virol (2004) 0.95
Different patterns of restriction to B19 parvovirus replication in human blast cell lines. Virology (2000) 0.95
Palindrome regeneration by template strand-switching mechanism at the origin of DNA replication of porcine circovirus via the rolling-circle melting-pot replication model. J Virol (2004) 0.92
Hypoxia enhances human B19 erythrovirus gene expression in primary erythroid cells. Virology (2004) 0.89
Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2. J Virol (1995) 0.85
Comparative genomics of emerging human ehrlichiosis agents. PLoS Genet (2006) 4.23
Hybrid DNA virus in Chinese patients with seronegative hepatitis discovered by deep sequencing. Proc Natl Acad Sci U S A (2013) 3.35
GDC-0449-a potent inhibitor of the hedgehog pathway. Bioorg Med Chem Lett (2009) 2.17
The family Parvoviridae. Arch Virol (2013) 2.12
Alterations in microRNA expression in stress-induced cellular senescence. Mech Ageing Dev (2009) 1.74
Molecular characterization of infectious clones of the minute virus of canines reveals unique features of bocaviruses. J Virol (2009) 1.61
Characterization and transcriptional analysis of gene clusters for a type IV secretion machinery in human granulocytic and monocytic ehrlichiosis agents. Infect Immun (2002) 1.61
Increased recognition of Powassan encephalitis in the United States, 1999-2005. Vector Borne Zoonotic Dis (2008) 1.59
Identification and characterization of a second novel human erythrovirus variant, A6. Virology (2002) 1.53
Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients. J Clin Microbiol (2002) 1.45
Evaluation of a new LightCycler reverse transcription-polymerase chain reaction infectivity assay for detection of human parvovirus B19 in dry-heat inactivation studies. Transfusion (2005) 1.44
Establishment of a reverse genetics system for studying human bocavirus in human airway epithelia. PLoS Pathog (2012) 1.43
Characterization of the gene expression profile of human bocavirus. Virology (2010) 1.40
Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication. J Virol (2007) 1.40
ELISAs using human bocavirus VP2 virus-like particles for detection of antibodies against HBoV. J Virol Methods (2008) 1.35
Mechanisms of variable p44 expression by Anaplasma phagocytophilum. Infect Immun (2003) 1.28
Targeting of integrin beta1 and kinesin 2alpha by microRNA 183. J Biol Chem (2009) 1.28
Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152). J Med Chem (2012) 1.27
Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome. J Virol (2008) 1.26
A first-in-human study of conatumumab in adult patients with advanced solid tumors. Clin Cancer Res (2010) 1.26
Production of human monoclonal antibody in eggs of chimeric chickens. Nat Biotechnol (2005) 1.25
Comparison of the transcription profile of simian parvovirus with that of the human erythrovirus B19 reveals a number of unique features. J Virol (2004) 1.21
Rapid sequential changeover of expressed p44 genes during the acute phase of Anaplasma phagocytophilum infection in horses. Infect Immun (2004) 1.21
Quantification of human bocavirus in lower respiratory tract infections in China. Infect Agent Cancer (2007) 1.20
Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency. Hum Gene Ther (2004) 1.16
Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. J Clin Invest (2010) 1.14
Cross-talk between miR-29 and transforming growth factor-betas in trabecular meshwork cells. Invest Ophthalmol Vis Sci (2011) 1.11
Role of miR-204 in the regulation of apoptosis, endoplasmic reticulum stress response, and inflammation in human trabecular meshwork cells. Invest Ophthalmol Vis Sci (2011) 1.10
Bocavirus infection induces mitochondrion-mediated apoptosis and cell cycle arrest at G2/M phase. J Virol (2010) 1.08
Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein. J Infect Dis (2006) 1.07
Extracellular release of ATP mediated by cyclic mechanical stress leads to mobilization of AA in trabecular meshwork cells. Invest Ophthalmol Vis Sci (2009) 1.07
Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD. Autophagy (2010) 1.04
Synthesis of oxytocin analogues with replacement of sulfur by carbon gives potent antagonists with increased stability. J Org Chem (2005) 1.03
Bocavirus infection induces a DNA damage response that facilitates viral DNA replication and mediates cell death. J Virol (2010) 1.03
Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells. J Virol (2010) 1.00
Identification and characterization of two internal cleavage and polyadenylation sites of parvovirus B19 RNA. J Virol (2006) 1.00
Parvovirus B19 infection of human primary erythroid progenitor cells triggers ATR-Chk1 signaling, which promotes B19 virus replication. J Virol (2011) 1.00
Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancer. J Med Chem (2010) 0.99
Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFα. PLoS Pathog (2011) 0.99
Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells. Food Chem Toxicol (2008) 0.98
MicroRNA-24 regulates the processing of latent TGFβ1 during cyclic mechanical stress in human trabecular meshwork cells through direct targeting of FURIN. J Cell Physiol (2011) 0.98
Regulation of trabecular meshwork cell contraction and intraocular pressure by miR-200c. PLoS One (2012) 0.97
hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways. J Biol Chem (2006) 0.97
Genomic features of the human bocaviruses. Future Virol (2012) 0.97
Modulation of inflammatory markers by miR-146a during replicative senescence in trabecular meshwork cells. Invest Ophthalmol Vis Sci (2010) 0.96
Significant species difference in amide hydrolysis of GDC-0834, a novel potent and selective Bruton's tyrosine kinase inhibitor. Drug Metab Dispos (2011) 0.96
Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest. Clin Cancer Res (2005) 0.96
VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones. Virology (2008) 0.96
The choice of translation initiation site of the rep proteins from goose parvovirus P9-generated mRNA is governed by splicing and the nature of the excised intron. J Virol (2009) 0.95
The capsid proteins of Aleutian mink disease virus activate caspases and are specifically cleaved during infection. J Virol (2009) 0.95
Molecular characterization of the newly identified human parvovirus 4 in the family Parvoviridae. Virology (2011) 0.95
Relationship between gene expression and function of uterotonic systems in the rat during gestation, uterine activation and both term and preterm labour. J Physiol (2008) 0.95
Parvovirus infection-induced cell death and cell cycle arrest. Future Virol (2010) 0.94
Human bocavirus 1 infects commercially available primary human airway epithelium cultures productively. J Virol Methods (2013) 0.94
Synthesis of biologically active dicarba analogues of the peptide hormone oxytocin using ring-closing metathesis. Org Lett (2003) 0.94
A novel bocavirus in canine liver. Virol J (2013) 0.94
Cytokine gene expression by peripheral blood leukocytes in horses experimentally infected with Anaplasma phagocytophila. Clin Diagn Lab Immunol (2002) 0.92
In vitro modeling of human bocavirus 1 infection of polarized primary human airway epithelia. J Virol (2013) 0.92
Differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution. Virology (2011) 0.92
Efficient expression of the adeno-associated virus type 5 p41 capsid gene promoter in 293 cells does not require Rep. J Virol (2006) 0.92
Characterization of the nonstructural proteins of the bocavirus minute virus of canines. J Virol (2012) 0.92
Proinflammatory cytokines inhibit human placental 11beta-hydroxysteroid dehydrogenase type 2 activity through Ca2+ and cAMP pathways. Am J Physiol Endocrinol Metab (2005) 0.91
Second generation 2-pyridyl biphenyl amide inhibitors of the hedgehog pathway. Bioorg Med Chem Lett (2010) 0.91
Simian parvovirus infection: a potential zoonosis. J Infect Dis (2004) 0.91
Reply to Naccache et al: Viral sequences of NIH-CQV virus, a contamination of DNA extraction method. Proc Natl Acad Sci U S A (2014) 0.91
Vaccination with recombinant Mycobacterium avium subsp. paratuberculosis proteins induces differential immune responses and protects calves against infection by oral challenge. Vaccine (2008) 0.90
Parvovirus B19 and onset of juvenile dermatomyositis. JAMA (2005) 0.89
Human parvovirus B19 DNA replication induces a DNA damage response that is dispensable for cell cycle arrest at phase G2/M. J Virol (2012) 0.88
The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells. PLoS One (2013) 0.88
Preclinical assessment of the absorption and disposition of the phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor GDC-0980 and prediction of its pharmacokinetics and efficacy in human. Drug Metab Dispos (2012) 0.88
Promotion of cellular migration and apoptosis resistance by a mouse eye-specific phosphatidylethanolamine-binding protein. Int J Mol Med (2007) 0.88
A novel chimeric adenoassociated virus 2/human bocavirus 1 parvovirus vector efficiently transduces human airway epithelia. Mol Ther (2013) 0.88
Internal polyadenylation of parvoviral precursor mRNA limits progeny virus production. Virology (2012) 0.88
Codon optimization of human parvovirus B19 capsid genes greatly increases their expression in nonpermissive cells. J Virol (2010) 0.88
Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication. J Virol (2013) 0.87
Metabolites of progesterone and the pregnane X receptor: a novel pathway regulating uterine contractility in pregnancy? Am J Obstet Gynecol (2005) 0.87
SMC1-mediated intra-S-phase arrest facilitates bocavirus DNA replication. J Virol (2013) 0.86
Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF. J Immunol (2013) 0.86
Structure of the NS1 protein N-terminal origin recognition/nickase domain from the emerging human bocavirus. J Virol (2013) 0.85
Molecular mechanism(s) involved in the synergistic induction of CXCL10 by human immunodeficiency virus type 1 Tat and interferon-gamma in macrophages. J Neurovirol (2008) 0.85
Bowel dysfunction after transposition of intestinal segments into the urinary tract: 8-year prospective cohort study. J Urol (2007) 0.84
Preclinical pharmacokinetics of the novel PI3K inhibitor GDC-0941 and prediction of its pharmacokinetics and efficacy in human. Xenobiotica (2011) 0.84
An 'all-inclusive' 96-well cytochrome P450 induction method: measuring enzyme activity, mRNA levels, protein levels, and cytotoxicity from one well using cryopreserved human hepatocytes. J Pharmacol Toxicol Methods (2012) 0.83
Protective effects of resveratrol in experimental retinal detachment. PLoS One (2013) 0.83
Construction and biological activity of a full-length molecular clone of human Torque teno virus (TTV) genotype 6. FEBS J (2007) 0.83
Establishment of an erythroid cell line from primary CD36+ erythroid progenitor cells. Exp Hematol (2010) 0.83
Safety and immunogenicity of a candidate parvovirus B19 vaccine. Vaccine (2011) 0.82